Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
TROP2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
A visual TROP2 target evaluation report for breast cancer, generated from PatSnap Target & Disease MCP and Clinical Trials MCP data, covering biology, validation evidence, competition, IP considerations, and R&D strategy.
8 min read
CLDN18.2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
A visual CLDN18.2 target evaluation report for gastric cancer, generated from PatSnap Target & Disease MCP and Clinical Trials MCP data, covering biology, validation evidence, competition, IP considerations, and R&D strategy.
8 min read
LAG3 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
A visual LAG3 target evaluation report for melanoma, generated from PatSnap Target & Disease MCP and Clinical Trials MCP data, covering biology, validation evidence, competition, IP considerations, and R&D strategy.
8 min read
TIGIT Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
A visual TIGIT target evaluation report for NSCLC, generated from PatSnap Target & Disease MCP and Clinical Trials MCP data, covering biology, validation evidence, competition, IP considerations, and R&D strategy.
8 min read
CTLA4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
A visual CTLA4 target evaluation report for melanoma, generated from PatSnap Target & Disease MCP and Clinical Trials MCP data, covering biology, validation evidence, competition, IP considerations, and R&D strategy.
8 min read
PD-L1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
A visual PD-L1 target evaluation report for NSCLC, generated from PatSnap Target & Disease MCP and Clinical Trials MCP data, covering biology, validation evidence, competition, IP considerations, and R&D strategy.
8 min read
PD-1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
A visual PD-1 target evaluation report for Melanoma, generated from PatSnap Target & Disease MCP and Clinical Trials MCP data, covering biology, validation evidence, competition, IP considerations, and R&D strategy.
8 min read
HER2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
A visual HER2 target evaluation report for Breast Cancer, generated from PatSnap Target & Disease MCP and Clinical Trials MCP data, covering biology, validation evidence, competition, IP considerations, and R&D strategy.
8 min read
EGFR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
A visual EGFR target evaluation report for NSCLC, generated from PatSnap Target & Disease MCP and Clinical Trials MCP data, covering biology, validation evidence, competitive intensity, IP considerations, and R&D strategy.
8 min read
KRAS Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
8 July 2026
A visual, MCP-data-backed KRAS target evaluation report using PatSnap Target & Disease MCP and Clinical Trials MCP for biology, disease context, trial competition, result evidence, and strategy.
Hot Spotlight
5 min read
PatSnap Open Platform Launches 12 Life Sciences MCP Servers for AI Agents
8 July 2026
Bring target, disease, drug, clinical, regulatory, chemistry, biologics, and market intelligence directly into your agent workflows.
Pharma Pioneer
8 min read
Stop Drowning in Data: Meet Synapse Lens, the Ultimate Reading Assistant for Biomed Professionals
5 February 2026
If you’ve ever felt overwhelmed by the sheer volume of reading required to stay ahead, there is a tool designed specifically for you. Introducing Synapse Lens, a Chrome extension hailed as a "superpower" for pharmaceutical and biotech professionals.